Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 491-496

  Tan, Xiaoyue ^a   Li, Yingjian ^a   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; EMT; HGF; Renal fibrosis; TGF ; Vitamin D

Indexed keywords

CALCITRIOL; VITAMIN D RECEPTOR;

ARTICLE; CALCIUM HOMEOSTASIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; EPITHELIUM CELL; HUMAN; IMMUNOMODULATION; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY STRUCTURE; MESANGIUM CELL; MESENCHYME CELL; MOLECULAR EVOLUTION; MYOFIBROBLAST; NEPHRITIS; NONHUMAN; PHENOTYPE; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; CELL DIFFERENTIATION; CHRONIC DISEASE; EPITHELIAL CELLS; FIBROSIS; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY DISEASES; RECEPTORS, CALCITRIOL; STEM CELLS; VITAMIN D;

EID: 33947134403     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.11.011     Document Type: Article

References (37)

1. Ishimura E., Nishizawa Y., Inaba M., Matsumoto N., Emoto M., Kawagishi T., Shoji S., Okuno S., Kim M., Miki T., and Morii H. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in non-dialyzed patients with chronic renal failure. Kidney Int. 55 (1999) 1019-1027
2. levin A., Bakris G.L., Molitch M., Smulders M., Tian J., Williams L.A., and Andress D.L. Prevalence of abnormal serum Vitamin D, PTH, calcium and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease (SEEK). J. Am. Soc. Nephrol. 16 (2005) 35A (Abstract)
3. Andress D.L. Vitamin D in chronic kidney disease: a systemic role for selective Vitamin D receptor activation. Kidney Int. 69 (2006) 33-43
4. Kuhlmann A., Haas C.S., Gross M.L., Reulbach U., Holzinger M., Schwarz U., Ritz E., and Amann K. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am. J. Physiol. Renal Physiol. 286 (2004) F526-F533
5. 2 Vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 53 (1998) 1696-1705
6. Tan X., Li Y., and Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J. Am. Soc. Nephrol. 17 (2006) 3382-3393
7. Hirata M., Makibayashi K., Katsumata K., Kusano K., Watanabe T., Fukushima N., and Doi T. 22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats. Nephrol. Dial. Transplant. 17 (2002) 2132-2137
8. Makibayashi K., Tatematsu M., Hirata M., Fukushima N., Kusano K., Ohashi S., Abe H., Kuze K., Fukatsu A., Kita T., and Doi T. A Vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Am. J. Pathol. 158 (2001) 1733-1741
9. 2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int. 60 (2001) 87-95
10. Schnaper H.W., Hayashida T., Hubchak S.C., and Poncelet A.C. TGF-beta signal transduction and mesangial cell fibrogenesis. Am. J. Physiol. Renal Physiol. 284 (2003) F243-F252
11. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69 (2006) 213-217
12. Bottinger E.P., and Bitzer M. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 13 (2002) 2600-2610
13. Agarwal R., Acharya M., Tian J., Hippensteel R.L., Melnick J.Z., Qiu P., Williams L., and Batlle D. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 68 (2005) 2823-2828
14. Sezer S., Uyar M., Arat Z., Ozdemir F.N., and Haberal M. Potential effects of 1,25-dihydroxyvitamin D3 in renal transplant recipients. Transplant. Proc. 37 (2005) 3109-3111
15. Griffin M.D., Lutz W., Phan V.A., Bachman L.A., McKean D.J., and Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a Vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6800-6805
16. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., and Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110 (2002) 229-238
17. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., and Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 89-90 (2004) 387-392
18. Li Y.C. Vitamin D regulation of the renin-angiotensin system. J. Cell. Biochem. 88 (2003) 327-331
19. Weinreich T., Merke J., Schonermark M., Reichel H., Diebold M., Hansch G.M., and Ritz E. Actions of 1,25-dihydroxyvitamin D3 on human mesangial cells. Am. J. Kidney Dis. 18 (1991) 359-366
20. Migliori M., Giovannini L., Panichi V., Filippi C., Taccola D., Origlia N., Mannari C., and Camussi G. Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis. Int. J. Immunopathol. Pharmacol. 18 (2005) 779-790
21. Li Y., Spataro B.C., Yang J., Dai C., and Liu Y. 1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int. 68 (2005) 1500-1510
22. Yang J., Dai C., and Liu Y. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction. Am. J. Pathol. 163 (2003) 621-632
23. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am. J. Physiol. Renal Physiol. 287 (2004) F7-F16
24. Liu Y., Michalopoulos G.K., and Zarnegar R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J. Biol. Chem. 269 (1994) 4152-4160
25. Dai C., and Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J. Am. Soc. Nephrol. 15 (2004) 1402-1412
26. Yang J., and Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13 (2002) 96-107
27. Yang J., Dai C., and Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. J. Am. Soc. Nephrol. 16 (2005) 68-78
28. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15 (2004) 1-12
29. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112 (2003) 1776-1784
30. Zeisberg M., Hanai J., Sugimoto H., Mammoto T., Charytan D., Strutz F., and Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9 (2003) 964-968
31. Yang J., and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159 (2001) 1465-1475
32. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., Del Barrio M.G., Portillo F., and Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell. Biol. 2 (2000) 76-83
33. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., and De Herreros A.G. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell. Biol. 2 (2000) 84-89
34. Kuphal S., Palm H.G., Poser I., and Bosserhoff A.K. Snail-regulated genes in malignant melanoma. Melanoma Res. 15 (2005) 305-313
35. Perk J., Iavarone A., and Benezra R. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer. 5 (2005) 603-614
36. Palmer H.G., Larriba M.J., Garcia J.M., Ordonez-Moran P., Pena C., Peiro S., Puig I., Rodriguez R., De la Fuente R., Bernad A., Pollan M., Bonilla F., Gamallo C., De Herreros A.G., and Munoz A. The transcription factor SNAIL represses Vitamin D receptor expression and responsiveness in human colon cancer. Nat. Med. 10 (2004) 917-919
37. Palmer H.G., Gonzalez-Sancho J.M., Espada J., Berciano M.T., Puig I., Baulida J., Quintanilla M., Cano A., De Herreros A.G., Lafarga M., and Munoz A. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell. Biol. 154 (2001) 369-387